134 related articles for article (PubMed ID: 17028772)
41. Multicentre validation of different predictive tools of non-sentinel lymph node involvement in breast cancer.
Cserni G; Boross G; Maráz R; Leidenius MH; Meretoja TJ; Heikkila PS; Regitnig P; Luschin-Ebengreuth G; Zgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Audisio RA
Surg Oncol; 2012 Jun; 21(2):59-65. PubMed ID: 22197294
[TBL] [Abstract][Full Text] [Related]
42. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
43. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
44. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.
Leidenius M; Salmenkivi K; von Smitten K; Heikkilä P
J Surg Oncol; 2006 Oct; 94(5):380-4. PubMed ID: 16967467
[TBL] [Abstract][Full Text] [Related]
45. In-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure.
van Deurzen CH; Borgstein PJ; van Diest PJ
J Clin Pathol; 2008 Dec; 61(12):1314-6. PubMed ID: 18794198
[TBL] [Abstract][Full Text] [Related]
46. Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications.
Groen RS; Oosterhuis AW; Boers JE
Breast Cancer Res Treat; 2007 Sep; 105(1):1-5. PubMed ID: 17221160
[TBL] [Abstract][Full Text] [Related]
47. Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node.
Hulvat M; Rajan P; Rajan E; Sarker S; Schermer C; Aranha G; Yao K
Surgery; 2008 Oct; 144(4):518-24; discussion 524. PubMed ID: 18847634
[TBL] [Abstract][Full Text] [Related]
48. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
[TBL] [Abstract][Full Text] [Related]
49. Sentinel node biopsy with intraoperative diagnosis in patients undergoing skin-sparing mastectomy and immediate breast reconstruction.
Meretoja TJ; Jahkola TA; Toivonen TS; Krogerus LA; Heikkilä PS; von Smitten KA; Leidenius MH
Eur J Surg Oncol; 2007 Dec; 33(10):1146-9. PubMed ID: 17462851
[TBL] [Abstract][Full Text] [Related]
50. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
51. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
52. Predictive factors of non-sentinel lymph node involvement in patients with invasive breast cancer and sentinel node micrometastases.
Friedman D; Gipponi M; Murelli F; Meszaros P; Solari N; Massa M; Depaoli F; Baccini P; Carli F; Gallo M; Cafiero F
Anticancer Res; 2013 Oct; 33(10):4509-14. PubMed ID: 24123023
[TBL] [Abstract][Full Text] [Related]
53. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
Scheri RP; Essner R; Turner RR; Ye X; Morton DL
Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
[TBL] [Abstract][Full Text] [Related]
54. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
55. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
[TBL] [Abstract][Full Text] [Related]
56. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
57. Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion.
Jonjic N; Mustac E; Dekanic A; Marijic B; Gaspar B; Kolic I; Coklo M; Sasso F
Int J Surg Pathol; 2006 Oct; 14(4):306-11. PubMed ID: 17041193
[TBL] [Abstract][Full Text] [Related]
58. Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours.
Leidenius MH; Krogerus LA; Toivonen TS; von Smitten KA
Eur J Surg Oncol; 2005 May; 31(4):364-8. PubMed ID: 15837040
[TBL] [Abstract][Full Text] [Related]
59. Can sentinel node biopsy be avoided in some elderly breast cancer patients?
Chagpar AB; McMasters KM; Edwards MJ;
Ann Surg; 2009 Mar; 249(3):455-60. PubMed ID: 19247034
[TBL] [Abstract][Full Text] [Related]
60. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.
Mansel RE; Goyal A; Douglas-Jones A; Woods V; Goyal S; Monypenny I; Sweetland H; Newcombe RG; Jasani B
Breast Cancer Res Treat; 2009 Jun; 115(3):595-600. PubMed ID: 18716862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
